Insider Transactions in Q1 2021 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
3,389
-11.25%
|
$274,509
$81.66 P/Share
|
|
Mar 15
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
3,389
+10.11%
|
$74,558
$22.29 P/Share
|
|
Mar 12
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
13,077
-21.23%
|
$1,072,314
$82.85 P/Share
|
|
Mar 12
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
13,077
+17.52%
|
$170,001
$13.98 P/Share
|
|
Mar 09
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
30,000
+1.0%
|
-
|
|
Mar 09
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
68,550
-8.4%
|
$5,621,100
$82.35 P/Share
|
|
Mar 09
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
30,000
-10.7%
|
-
|
|
Mar 09
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
98,550
+24.14%
|
$1,281,150
$13.98 P/Share
|
|
Mar 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.38%
|
$514,350
$81.37 P/Share
|
|
Mar 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+6.0%
|
$133,350
$21.76 P/Share
|
|
Mar 01
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct |
13,020
-4.35%
|
$1,093,680
$84.85 P/Share
|
|
Mar 01
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
13,020
+7.88%
|
$169,260
$13.98 P/Share
|
|
Mar 01
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-2.11%
|
$649,890
$83.99 P/Share
|
|
Mar 01
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+2.07%
|
$274,050
$35.2 P/Share
|
|
Feb 23
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
30,000
+1.01%
|
-
|
|
Feb 23
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
30,000
-12.44%
|
-
|
|
Feb 23
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
68,550
-5.97%
|
$5,758,200
$84.46 P/Share
|
|
Feb 23
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
98,550
+24.14%
|
$1,281,150
$13.98 P/Share
|
|
Feb 16
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
3,389
-11.25%
|
$298,232
$88.2 P/Share
|
|
Feb 16
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
3,389
+10.11%
|
$74,558
$22.29 P/Share
|
|
Feb 11
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
11,745
-11.19%
|
$1,010,070
$86.81 P/Share
|
|
Feb 11
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
11,661
+10.0%
|
$151,593
$13.98 P/Share
|
|
Feb 05
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
13,077
-21.23%
|
$1,111,545
$85.8 P/Share
|
|
Feb 05
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
13,077
+17.52%
|
$170,001
$13.98 P/Share
|
|
Feb 04
2021
|
Nicholas J Valeriani Director |
SELL
Open market or private sale
|
Direct |
8,200
-12.08%
|
$697,000
$85.21 P/Share
|
|
Feb 04
2021
|
Nicholas J Valeriani Director |
BUY
Exercise of conversion of derivative security
|
Direct |
22,608
+24.98%
|
$452,160
$20.76 P/Share
|
|
Feb 01
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct |
20,523
-12.85%
|
$1,703,409
$83.51 P/Share
|
|
Feb 01
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
20,523
+6.18%
|
$246,276
$12.67 P/Share
|
|
Jan 15
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
3,389
-11.25%
|
$294,843
$87.27 P/Share
|
|
Jan 15
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
3,389
+10.11%
|
$74,558
$22.29 P/Share
|
|
Jan 15
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
11,730
-11.17%
|
$1,020,510
$87.27 P/Share
|
|
Jan 15
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
11,649
+9.98%
|
$151,437
$13.98 P/Share
|
|
Jan 15
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
30,000
+1.02%
|
-
|
|
Jan 15
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
68,550
-12.38%
|
$5,963,850
$87.7 P/Share
|
|
Jan 15
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
30,000
-9.85%
|
-
|
|
Jan 15
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
98,550
+24.14%
|
$1,281,150
$13.98 P/Share
|
|
Jan 08
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
13,077
-11.18%
|
$1,176,930
$90.54 P/Share
|
|
Jan 08
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
13,077
+17.52%
|
$170,001
$13.98 P/Share
|
|
Jan 04
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct |
20,523
-12.85%
|
$1,867,593
$91.24 P/Share
|
|
Jan 04
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
20,523
+6.18%
|
$246,276
$12.67 P/Share
|